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Results from multiple diagnostic tests are usually combined to improve the overall diagnostic accuracy. For binary
classification, maximization of the empirical estimate of the area under the receiver operating characteristic (ROC)
curve is widely adopted to produce the optimal linear combination of multiple biomarkers. In the presence of large
number of biomarkers, this method proves to be computationally expensive and difficult to implement since it
involves maximization of a discontinuous, non-smooth function for which gradient-based methods cannot be used
directly. Complexity of this problem increases when the classification problem becomes multi-category. In this
article, we develop a linear combination method that maximizes a smooth approximation of the empirical Hyper-
volume Under Manifolds (HUM) for multi-category outcome. We approximate HUM by replacing the indicator
function with the sigmoid function or normal cumulative distribution function (CDF). With the above smooth
approximations, efficient gradient-based algorithms can be employed to obtain better solution with less computing
time. We show that under some regularity conditions, the proposed method yields consistent estimates of the
coefficient parameters. We also derive the asymptotic normality of the coefficient estimates. We conduct extensive
simulations to examine our methods. Under different simulation scenarios, the proposed methods are compared
with other existing methods and are shown to outperform them in terms of diagnostic accuracy. The proposed
method is illustrated using two real medical data sets. Copyright c© 2019 John Wiley & Sons, Ltd.
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1. Introduction
Statistical classification methods are widely used in various fields such as economics, computer science, meteorology,
and medicine. Specifically, in medicine, diagnostic tests are employed as effective “classifiers” to discriminate diseased
individuals from the non-diseased. Over the recent decades, many research articles recommended combining multiple test
results in order to increase the overall diagnostic accuracy. Common approaches to combine multiple test results include
the logistic regression (LR), the linear discriminant analysis (LDA) and other model-based approaches. Some authors
([1], [2], [3]) directly focused on the maximization of the Area Under the Receiver Operating Characteristic (ROC) Curve
(AUC) to combine multiple test results. However, to the best of our knowledge, there is only limited development for
finding the optimal linear combination of diagnostic tests in case of multivariate classification problems.
For binary classification, earlier works considered maximizing various non-parametric estimates of AUC to obtain
the best linear combination of the biomarkers ([2], [4], [5], [6], [7], among others). In particular, [3] proposed to
maximize an empirical estimate of AUC in the form of a Mann-Whitney U-statistic for obtaining the best solution.
However, maximization of the empirical AUC remains computationally challenging since the objective function is
discontinuous and non-differentiable. To reduce the computational complexity, [6] considered maximizing a smooth
consistent approximation of the empirical AUC using the sigmoid function to estimate the optimal coefficient parameters
for the binary classification scenario. For multivariate classification problems, [7] proposed a min-max method where only
the biomarkers with the minimum and the maximum values are considered for each subject, and then they are combined
linearly by maximizing the empirical AUC. Thus, irrespective of the number of biomarkers, min-max method estimates
only one coefficient at a time which is computationally less expensive.
When a disease outcome involves more than two categories, Hyper-volume Under the ROC Manifold (HUM) is
commonly used as a multi-category extension of AUC ([8]). In such problems, the goal is to find the optimal combination
of biomarkers that maximizes the diagnostic accuracy measure HUM. For a three-category outcome, HUM is also known
as the Volume under ROC Surface (VUS), and has also been considered in the context of some real applications ([9],
[10], [11]). To evaluate the HUM values for single marker or multiple markers under existing learning methods, one may
adopt R packages HUM [12] and mcca [13], respectively. [14] maximized the empirical estimate of VUS to combine
multiple biomarkers. Due to non-differentiability of the objective function, maximization of empirical VUS requires
derivative-free optimization methods which are computationally expensive, especially when the number of biomarkers
is large. To overcome this problem, under normality assumption, [15] used a penalized and scaled stochastic distance
method to combine multiple biomarkers, which was computationally less demanding. However, violation of the normality
assumption of biomarkers may lead to poor estimation performance. [16] constructed upper and lower bounds of the
HUM using Fre´chet inequality and showed that these bounds are functions of AUCs of all possible pairwise adjacent
categories. Then they maximized the empirical estimates of such upper and lower bounds to obtain the optimal linear
combination. This technique reduces the computational complexity. However, such approximations do not perform well
for small sample sizes and/or non-normal distributions (as is observed in our simulation study).
In this article, we propose to maximize the distribution-free Smooth approximation of empirical HUM (SHUM) to
combine multiple biomarkers in an effective way. In particular, the sigmoid function and the normal cumulative distribution
functions (CDF) are used to approximate the non-differentiable indicator functions embedded in the definition of HUM.
We show that the proposed method yields consistent estimates of the optimal coefficients and they are asymptotically
normal. A major advantage with the proposed method stems from the fact that SHUM is a continuous and differentiable
function; this feature of SHUM allows one to adopt a variety of gradient-based optimization algorithms. Maximizing
empirical HUM with derivative-free optimization techniques, such as Nelder-Mead simplex method, genetic algorithm
(GA), and simulating annealing (SA), are computationally expensive. However, gradient-based optimization techniques
like Newton-Raphson and Quasi-Newton methods can be applied to maximize the SHUM function; these nonlinear solvers
are much more stable with nice convergence properties. In addition to the theoretical developments, we also carry out
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extensive simulations to examine our methods and compare their performance with other existing methods, e.g., the min-
max method ([7]), the lower and upper bound methods ([16]), the empirical method ([14]) and the parametric method with
normal distribution ([17]).
As a motivating application, we consider data from the Effect of Remote Ischemic Preconditioning on Clinical
Outcomes in Patient Undergoing Coronary Artery Bypass Graft Surgery (ERICCA) trial where a group of patients
participated in a cardiovascular surgery and were followed for one year after the surgery ([18]). During the study period,
patients might have developed Acute Kidney Injury (AKI) which was recorded as a multi-category ordinal outcome with
4 severity levels. In another application, we consider data on Alzheimer’s disease from the Alzheimers Disease Research
Center (ADRC) at the University of Washington. There, based on the level of disease severity, the patients were divided
into 3 groups and data on 14 biomarkers were collected. For both the datasets, we apply our proposed methods to combine
the biomarkers and compare the results with the competing methods.
The rest of the article is organized as follows. In Section 2, HUM and SHUM are defined along with discussion on
the large sample properties of the estimated combination coefficients. In Section 3, existing methods are summarized in
an overview. In Section 4, we provide a discussion on computational issues. In section 5, we present results from the
simulation studies. Section 6 describes the results and findings from two real data analyses. Section 7 contains discussion
and concluding remarks. All the proofs of theoretical results can be found in the Appendix.
2. Methods
In this section, we introduce the HUM and SHUM methods for combining multiple markers to improve the multi-category
classification accuracy.
2.1. Hyper-volume Under ROC Manifold (HUM)
Consider a study where there are M multiple diagnostic/disease categories which are assumed to be ordered in nature
without loss of generality. We provide some practical suggestion later for unordered classes. SupposeX1,X2, · · · ,XM are
d-dimensional random selected vectors representing the values of d biomarkers for M diagnostic/disease categories where
Xj = (Xj1, Xj2, · · · , Xjd)T and Xjk denotes the value of the k-th biomarker from the j-th category, k = 1, 2, · · · , d and
j = 1, 2, · · · ,M . Suppose Xj follows multivariate continuous distribution Fj . Consider a linear combination of these
biomarkers as
βTXj =
d∑
k=1
βjXjk, j = 1, 2, · · · ,M,
where β = (β1, β2, · · · , βd)T is a d-dimensional vector of parameters. Under the assumption that the larger value of the
above combination corresponds to more severe disease category, a diagnostic accuracy measure can be defined by the
following probability
D(β) = P (βTXM > β
TX(M−1) > · · · > βTX1),
which is known as hyper-volume under the ROC manifolds (HUM) ([9], [8]). For multi-category ordinal outcome, HUM
can be considered as an extension of the AUC which is widely used for binary diagnostic accuracy studies. Our objective is
to find the best possible value of β for whichD(β) is maximized. Ideally, if there exist a β for whichD(β) = 1, using such
a combination the diagnostic categories would be perfectly separated. Let β0 denote the optimal coefficient parameter that
maximizes D(β) over a restricted parametric space B,
β0 = arg max
β∈B
D(β),
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where the restricted space B = {β ∈ Rd : βd = 1} is considered to avoid the identifiability problem. Denote θ =
(β1, β2, · · · , βd−1)T to be the first d− 1 components of β which are the actual coefficient parameters free to vary in the
d− 1 dimensional Euclidean space. Hereafter, for the simplicity of presentation, we use β in place of β(θ) = (θT , 1)T .
If the biomarkers are non-informative in predicting the disease categories then D(β) will be close to the probability of a
random sorting 1M ! . Under the assumption that X1,X2, · · · ,XM are generated from multivariate normal distribution, a
unique solution for β0 can be derived under some regularity conditions, ([1]). However, in general for non-normal data,
there does not exist such closed form expression of β0 and numerical optimizer must be utilized.
2.2. Empirical HUM
Now let us consider the problem of estimating β0 given an empirical sample. Let {Xjij ; ij = 1, 2, · · · , nj , j =
1, 2, · · · ,M} be a sample of size n = ∑Mj=1 ni observations where j = 1, . . . ,M denote diagnostic categories and
ij = 1, 2, · · · , nj denote the samples in the j-th category. Then, for a fixed β, the empirical HUM is given by
DE(β) =
1
n1n2 · · ·nM
n1∑
i1=1
n2∑
i2=1
· · ·
nM∑
iM=1
I(βTXMiM > β
TX(M−1)i(M−1) > · · · > βTX1i1)
=
1
M∏
i=1
ni
n1∑
i1=1
n2∑
i2=1
· · ·
nM∑
iM=1
I(βTXMiM > β
TX(M−1)i(M−1)) · · · I(βTX2i2 > βTX1i1)
(1)
where I(·) denotes the indicator function. When sample size is large, DE(β) is a very close approximation to D(β).
Therefore an optimal coefficient parameter can be estimated by
β̂E = arg max
β∈B
DE(β).
When the number of disease categories is 2 (i.e., M = 2), the empirical HUM reduces to the empirical estimate of AUC
given by
DE(β) =
1
n1n2
n1∑
i1=1
n2∑
i2=1
I(βTX2i2 > β
TX1i1),
and when M = 3, it reduces to the empirical VUS given by
DE(β) =
1
n1n2n3
n1∑
i1=1
n2∑
i2=1
n3∑
i3=1
I(βTX3i3 > β
TX2i2 > β
TX1i1). (2)
Under some regularity conditions, [14] established the consistency and asymptotic normality of β̂E for three-category
outcome. Following their argument, the consistency and asymptotic normality of β̂E for more than three categories can be
similarly established. However, upon close examination, we notice thatDE(β) is discontinuous and not differentiable w.r.t.
β, and hence faster gradient-based algorithms are not useful to this optimization problem. On the other hand, although
derivative-free algorithms can be used for small number of categories, say M = 2 or 3, with the increase in the number of
categories derivative-free algorithms become computationally prohibitive and instable. To address this issue, in the next
section, we propose a new method based on smooth approximation.
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Figure 1. Sigmoid and normal CDF functions for different choices of tuning parameter λn
2.3. Smooth Approximation of empirical HUM
In order to alleviate the computational burden of maximizing the sample version HUM, as an alternative we propose to
maximize a class of smooth approximations of the empirical HUM. The basic idea is to approximate the non-differentiable
indicator function I(x > 0). We focus on the class of all continuous distribution functions g(x) with support over
(−∞,∞), satisfying g(x) + g(−x) = 1 and g′′(x) is continuous. Having g′′(x) continuous and replacing all indicator
functions with this kind of approximation function makes the approximate objective function solvable with gradient-
based optimization algorithms such as the Newton-Raphson methods and the Quasi-Newton methods. In this paper, we
consider two smooth candidates which are the sigmoid function s(x) = 11+exp(−x) , and the standard normal CDF denoted
by Φ(x) = P (χ ≤ x) where χ follows a normal distribution with mean 0 and variance 1. Under the binary classification
scenario, [6] proposed the sigmoid approximation of the empirical AUC to seek β0. However this approach has never been
extended for multi-category classification scenario to the best of our knowledge.
As the value of x goes away from 0, s(x) tends to get closer to I(x). When x is close to 0, the absolute difference
between s(x) and I(x) is the highest. This also holds true for Φ(x). Therefore, in order to improve the approximation
of these functions, a tuning parameter λn is introduced and we approximate I(x) by sn(x) = s( xλn ) =
1
1+exp(−x/λn) and
Φn(x) = Φ(x/λn) where λn satisfies limn→∞ λn = 0.
The choice of λn is very crucial in the performance of the smoothed HUM function. When λn is close to 0, the proposed
SHUM estimator behaves similarly to the empirical HUM with a very large value of derivative across a very small interval
around zero. This induces a greater variability on the resulting estimators. On the other hand, if λn is chosen to be one,
it suffers from biased approximation. Therefore, we need to choose an optimal λn between 0 and 1 to strike a balance
between the bias and the variance issues. To illustrate the role of λn, a graphical representation is displayed in Figure
1 where we consider a few selected values of λn. We can see that as λn decreases to zero the approximation becomes
closer to the indicator function I(x). As a rule of thumb, [19] and [6] recommended λn should be chosen ensuring
that |βT (X1i1 −X2i2)/λn| > 5 is satisfied for most of the pairs (i1, i2). In this paper after experimenting with different
possible values of λn, we set λn = 1√n for our simulation studies and real data analysis, which satisfies the empirical
condition.
Although the smoothing approximation can be done through either gn = sn or gn = Φn, hereafter we only present the
results for the sigmoid smoothing approximation to save the space. Applying this proposed function approximation to
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DE(β), the proposed sigmoid smooth approximation function for multi-categorical problem is given by
Dsn(β) =
1
n1n2 · · ·nM
n1∑
i1=1
n2∑
i2=1
· · ·
nM∑
iM=1
sn(β
T (XMiM −X(M−1)i(M−1))) · · · sn(βT (X2i2 −X1i1)). (3)
We propose to maximize Dsn(β) in order to estimate the optimal coefficient vector. The optimal vector of combination is
estimated by
β̂sn = arg maxβ∈B
Dsn(β).
We denote the optimal coefficient estimate obtained using the sigmoid smooth approximation of the empirical HUM
(SSHUM) as β̂sn and using the normal smooth approximation of the empirical HUM (NSHUM) by β̂Φn .
2.4. Consistency and Asymptotic Normality of SSHUM
Under some regularity conditions, we establish the consistency and asymptotic normality of β̂sn . We list the set of
necessary regularity conditions as follows.
A1. The support space of Xjij is not contained in any proper linear subspace of Rd.
A2. There exist at least one component of Xjij which has positive density everywhere conditional on the other
components, almost surely.
A3. The true parameter value β0 is an interior point of B which is a compact subset of Rd.
Theorem 1 (Consistency) Suppose that assumptions (A1)-(A3) hold, then
β̂sn
p−→ β0
as n→∞, where “ p−→” denotes convergence in probability.
The detailed proof of Theorem 1 is provided in section A1 in the appendix. In order to prove the
asymptotic normality of β̂sn , we assume additional set of regularity conditions. Denote Ψ(X1i1 ,X2i2 ,XMiM ;β) =
∂
∂θ
[
sn(β
T (XMiM −X(M−1)i(M−1))) · · · sn(βT (X2i2 −X1i1))
]
. Then assume the following:
A4. A(β0) = E
(
− ∂
∂θT
Ψ(X1i1 ,X2i2 ,XMiM ;β0)
)
<∞ and is invertible.
A5. Ψ˜m1(Xm1;β0) = E
(
∂
∂θ
Ψ(X11,X21,XM1;β0)|Xm1
)
is having the finite variance-covariance matrix, i.e.,
Σψm = V ar(Ψ˜m1(Xm1;β0)) <∞ for all m = 1, 2, · · · ,M .
A6. limn→∞
n
nm
= ρ2m <∞ for all 1 ≤ m ≤M .
Assumptions (A4)-(A6) ensure that the asymptotic variance exits and is finite.
Theorem 2 (Asymptotic normality) Suppose that the regularity conditions (A1)-(A6) hold, then
√
n(β̂sn − β0)
D−→ (WT , 0)T
as n −→∞ where “ D−→” denotes convergence in distribution and W is a (d− 1)-variate normal distribution
N(0,A−1(β0)B(β0){A−1(β0)}T ), where
B(β0) =
M∑
m=1
ρ2mΣψm .
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Remark: Computation of variance of β̂sn using the asymptotic variance formula given in Theorem 2 is very tedious
and challenging, especially because of the choice of the kernel function g given in equation (??). Furthermore, it is
noticed that the U-statistic based asymptotic variance formula are not generally reliable for small sample size for the
direct maximization of the empirical HUM (see [8]). In such cases, bootstrap technique is usually employed to compute
the variances of the coefficient estimators of βsn .
3. Existing Methods
In this section, we provide a brief summary of the existing methods which can be used to obtain the optimal coefficient
vector for biomarker combinations. In the simulation study section, we shall compare the proposed methods with these
methods.
3.1. Parametric Method with Normality Assumption (Parametric)
[17] proposed the parametric method with normality assumption of the biomarkers in order to obtain the optimal linear
combination of biomarkers. This approach assumes that Fj , the distribution of biomarkers from the jth category Xj ,
is a multivariate normal distribution with mean vector µj and variance-covariance matrix Σj , j = 1, 2, · · · ,M . Then,
the linear combination of biomarkers Xj for the j-th category, denoted by Vj = βTXj , follows a univariate normal
distribution with mean βTµj and variance β
TΣjβ, i.e., Vj ∼ N(βTµj ,βTΣjβ) j = 1, 2, · · · ,M . Let φ and Φ denote the
density function and cumulative distribution function of the standard normal distribution N(0, 1). For M = 3, the HUM
D(β) can be shown to be equal to
DN (β) =
∫ ∞
−∞
Φ
(√
βTΣ2β√
βTΣ1β
u+
βT (µ2 − µ1)√
βTΣ1β
)
Φ
(
−
√
βTΣ2β√
βTΣ3β
u+
βT (µ3 − µ2)√
βTΣ3β
)
φ(u) du.
(4)
Maximizing DN (β) with respect to β, we obtain the optimal coefficient estimates as
βN = arg max
β∈B
DN (β).
Following the results of [1], it can be shown that if X1,X2, · · · ,XM are multivariate normally distributed with mean
vectors µ1, µ2, · · · , µM , respectively and common variance-covariance matrix Σ satisfying
µ2 − µ1 = µ3 − µ2 = · · · = µM − µM−1 = δ, (5)
the optimal coefficient parameters β̂N will be proportional to Σ−1δ, i.e., β̂N ∝ Σ−1δ. Once we have the sample estimates
for the mean and covariance parameters, we can plug-in them into the formula of β̂N to obtain the coefficient estimates.
A major advantage of using normality assumption is that it is computationally very easy, especially when (5) holds true.
However, the method fully depends on the normality assumption. Violation of the normality assumption may result in
poor estimate of β0.
3.2. Min-Max Method (Min-Max)
The Min-Max (MM) method is a more simplified non-parametric approach to combine the multiple biomarkers. It was
originally proposed by [7] in the context of binary outcome. Instead of considering all the biomarkers, this method
considers the empirical AUC based on the linear combination of two extreme biomarkers for each subject in the study. In
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this paper, to facilitate a comparative study, we define the empirical HUM based on the combination of the minimum and
maximum biomarkers for each subject.
Let Xjij ,max = max1≤k≤dXjij ,k and Xjij ,min = min1≤k≤dXjij ,k and define the linear combination of these two
extreme observations as Vjij = βmaxXjij ,max + βminXjij ,min, i = 1, 2, · · · , nj , j = 1, 2, · · · ,M . Then the objective
function to be maximized to obtain the optimal coefficient vector is given by
DMM (β) =
1
M∏
j=1
nj
n1∑
i1=1
n2∑
i2=1
· · ·
nM∑
iM=1
I(VMiM > V(M−1)iM−1 > · · · > V1i1). (6)
The optimal coefficient estimates by maximizing the above quantity can be written as
β̂MM = arg max
β∈B
DMM (β).
A major advantage of this method is that it involves the optimization of a single parameter as opposed to other competing
methods, and hence computationally it is very efficient. Furthermore, it does not need to assume any distributional
assumption of the data and hence is more robust against the parametric methods. So far, the method is studied only in
the context of binary disease outcome and it is observed that the method can achieve higher sensitivity over a certain
range of specificity. In other words, when someone is interested in partial AUC, this methods works better. However a
major limitation of this method is that a major portion of the informations on the biomarkers are not utilized since only
maximum and minimum biomarkers values are used.
3.3. Upper and Lower Bound Approach using Fre´chet inequality (Fre´chet)
To reduce computational burden of maximizing the empirical HUM in case of higher number of disease categories and/or
number of biomarkers, [16] proposed the upper and lower bounds of HUM which are given by
max{0, (M − 1)PA(β)− (M − 2)} ≤ D(β) ≤ PM (β),
where PA(β) and PM (β) are defined as follows
PA(β) =
M−1∑
j=1
P (βTXj+1 > β
TXj)/(M − 1),
and
PM (β) = min
1≤j≤M−1
P (βTXj+1 > β
TXj).
Instead of maximizing HUM, they proposed to maximize PA(β) or PM (β) in order to obtain the optimal combination.
For example, maximizing PM (β) with respect to β we obtain β̂Frechet = arg maxβ∈B PM (β) which can be considered
as an optimal coefficient vector.
The above method is computationally efficient against the direct maximization of HUM as it only considers pairs from
the adjacent categories, i.e., binary outcomes. The above method is computationally less time consuming than the HUM
when the number of disease categories is more than two. However, when pairwise discrimination among the disease
categories are not relevant to the overall discrimination, this method might perform poorly.
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4. Step-down Algorithm for Optimization
Step-down algorithm was originally proposed by [3] to combine multiple biomarkers in the context of binary diagnostic
outcomes. The main motivation of using step-down algorithm is its ability to optimize the elements of the β vector
sequentially one at a time instead of attempting to optimize them simultaneously. [15] formalized the step-down algorithm
in the context of three-category diagnostic outcomes. Recently [16] used this algorithm to maximize upper or lower bound
of HUM and obtained an optimal linear coefficient estimates. The algorithm to maximize a criteria function (e.g., SHUM)
goes as follows:
Step 1. Compute the SHUM for each individual d biomarkers using one at a time and arrange covariates in decreasing order
with respect to the computed SHUM values such that X(1) and X(d) have the highest and the lowest individual
SHUM values respectively..
Step 2. Choose the first two biomarkers with the highest SHUM values and combine them as V2 = X(1) + λ2X(2).
Step 3. Maximize the SHUM for the combined marker V2 w.r.t. λ2 and obtain V̂2 = X(1) + λ̂2X(2).
Step 4. For i = 3, . . . , d construct Vi = V̂i−1 + λiX(i) and maximize Vi w.r.t. λi and obtain λ̂i.
Thus at the end of step 4, the estimated optimal combination V̂d = X(1) + λ̂2X(2) + · · ·+ λ̂dX(d) is obtained. Although
this algorithm has been widely used to maximize empirical HUM for binary and three-category cases, here we mainly
use a gradient-decent based algorithm, namely quasi-Newton method to maximize all the stepwise SHUM values. We
implement the numerical method using the in-built function optim in the R software freely available in www.cran.org.
5. Simulation Study
To compare the performance of the proposed method with the existing methods, we perform experiments based on various
simulation scenarios. We consider three biomarkers and three-category ordinal outcome Y ∈ {0, 1, 2}, such that higher
values of biomarkers represent higher disease category. To explore the performance of the methods under different case
scenarios, we consider three examples based on normal distribution (with different correlation structure) and one based on
Weibull distribution to represent the non-normal and skewed family.
Scenario 1 : For the i-th category, the values of the biomarkers are simulated from three dimensional normal
distributions with mean vector µi, and common variance covariance matrix as identity Σ = I; i = 0, 1, 2. We set the
parameter values asµ0 = (0, 0, 0)T ,µ1 = (1.0, 1.1, 1.2)T , andµ2 = (2.0, 2.2, 2.4)T for categories i = 0, 1, 2, respectively.
Since the correlation matrix is considered to be identity with normal distributions, the biomarkers are independent to each
other.
Scenario 2 : In the second scenario, the mean vectors are same as in Scenario 1, however the covariance matrix
Σ = ((σst)) is such that all the diagonal elements are 1, i.e, σss = 1; and all the off-diagonal elements are 0.2, i.e.,
σst = 0.2, s 6= t; s, t = 1, 2, 3. This variance covariance matrix is an example of exchangeable matrix. Since all the off-
diagonal elements are non-zero and equal, therefore the biomarkers are correlated.
Scenario 3 : In the third scenario, the mean vectors are same as the previous scenarios. The covariance matrix has
an AR(1) form, i.e., all the diagonal elements are 1; and the off-diagonal elements are set as σst = 0.2|s−t|, s 6= t;
s, t = 1, 2, 3. Here all the mutual correlations are non-zero but it fades as the distance between two biomarkers increases.
Scenario 4 : In the fourth scenario, values of the biomarkers are simulated from Weibull distribution. Specifically, the
j-th biomarker from the i-th disease category follows a Weibull distribution with shape parameter kj and scale parameter
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λi and the probability density function is given by
f(x; kj , λi) =

ki
λi
(
x
λi
)kj−1
exp(−( xλj )kj ) x > 0,
0 x ≤ 0,
i = 0, 1, 2 and j = 1, 2, 3. Values of the shape parameter k and scale parameter λ are set as (k1, k2, k3) = (0.5, 1, 1.5)
and (λ1, λ2, λ3) = (1, 2, 3), respectively. Here, we assume that biomarkers are independently distributed. This case
corresponds to non-normal and skewed distribution.
5.1. Performance Evaluation
For each of the above-mentioned scenarios, we considered three sample sizes n = 60, 90, 120. Performance of the
proposed SSHUM and NSHUM methods are compared with the existing methods, namely the empirical method ([14]),
the Frechet bounds method ([16]), the parametric method ([17]) and the Min-Max method ([7]). Using all these methods,
we first estimated the optimal coefficient vector β and then calculated the maximized HUM values at those solutions.
The above procedure was repeated for 500 times to obtain the mean and standard error of the optimal solutions of β and
the corresponding HUM DE(β). The mean and standard errors of HUM for different methods are reported in Table 1,
whereas those values for the coefficient vector are reported in Table 2.
Under all the above scenarios, the proposed SSHUM and NSHUM methods outperform the other existing approximation
methods. Under the first three scenarios where biomarkers’ values are generated from normal distributions, the SSHUM
and NSHUM methods performs as good as the parametric method in Section 3.1 and outperform the Frechet bounds
method and Min-Max method. In Scenario 4 where biomarkers’ values are non-normally distributed, the parametric
method with normality assumption performs poorly than the proposed methods. However, there is no observable difference
in the accuracy measure between the SSHUM and NSHUM methods, suggesting both the sigmoid and the normal CDF
approximations perform equally good for non-normal distributions.
Table 1. Means and standard errors (in parenthesis) of obtained EHUM values at the optimal coefficient vector
estimated using the methods: the Empirical method ([14]), the Fre´chet bounds method ([16]), the parametric
method ([17]), the Min-Max method, SSHUM and NSHUM for simulation Scenarios 1, 2, 3, 4 with sample sizes
(60, 60, 60), (90, 90, 90), (120, 120, 120), based on 1000 repetitions.
(n1, n2, n3) Empirical Min-Max Parametric Fre´chet SSHUM NHSUM
Scenario 1 (True HUM=0.833)
(60, 60, 60) 0.824 (0.032) 0.804 (0.035) 0.826 (0.032) 0.813 (0.034) 0.828 (0.033) 0.828 (0.033)
(90, 90, 90) 0.825 (0.026) 0.805 (0.028) 0.827 (0.027) 0.815 (0.026) 0.827 (0.026) 0.827 (0.026)
(120, 120, 120) 0.824 (0.022) 0.804 (0.023) 0.825 (0.022) 0.813 (0.022) 0.825 (0.022) 0.825 (0.022)
Scenario 2 (True HUM=0.720)
(60, 60, 60) 0.747 (0.039) 0.734 (0.039) 0.752 (0.039) 0.744 (0.039) 0.754 (0.039) 0.754 (0.039)
(90, 90, 90) 0.748 (0.032) 0.735 (0.032) 0.750 (0.031) 0.744 (0.032) 0.752 (0.031) 0.752 (0.031)
(120, 120, 120) 0.749 (0.026) 0.736 (0.027) 0.751 (0.026) 0.745 (0.027) 0.752 (0.026) 0.752 (0.026)
Scenario 3 (True HUM=0.770)
(60, 60, 60) 0.766 (0.037) 0.752 (0.038) 0.770 (0.037) 0.756 (0.039) 0.773 (0.037) 0.773 (0.037)
(90, 90, 90) 0.767 (0.030) 0.753 (0.031) 0.769 (0.031) 0.756 (0.031) 0.771 (0.030) 0.771 (0.030)
(120, 120, 120) 0.769 (0.026) 0.754 (0.026) 0.770 (0.026) 0.758 (0.026) 0.771 (0.026) 0.772 (0.026)
Scenario 4 (True HUM=0.514)
(60, 60, 60) 0.452 (0.059) 0.412 (0.044) 0.436 (0.057) 0.391 (0.043) 0.521 (0.045) 0.521 (0.046)
(90, 90, 90) 0.474 (0.051) 0.412 (0.036) 0.425 (0.058) 0.391 (0.038) 0.515 (0.036) 0.515 (0.036)
(120, 120, 120) 0.484 (0.046) 0.411 (0.031) 0.420 (0.047) 0.392 (0.033) 0.512 (0.031) 0.512 (0.031)
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Table 2. Means (biases and standard errors) of (β1, β2)T (based on 1000 replications) by different methods for Scenario
1. All the methods were maximized using Quasi-Newton method.
Sample size (β1, β2)T Empirical Parametric Fre´chet SSHUM NSHUM
Scenario 1
n = (60, 60, 60) 1.2 1.045 (-0.155, 0.179) 1.230 (0.030, 0.294) 1.995 (0.795, 0.067) 1.275 (0.075, 0.367) 1.308 (0.108, 0.377)
1.1 1.018 (-0.082, 0.170) 1.124 (0.024, 0.284) 1.990 (0.890, 0.070) 1.182 (0.082, 0.382) 1.215 (0.115, 0.384)
n = (90, 90, 90) 1.2 1.050 (-0.15, 0.125) 1.230 (0.030, 0.229) 1.998 (0.798, 0.062) 1.274 (0.074, 0.297) 1.282 (0.082, 0.311)
1.1 1.010 (-0.09, 0.113) 1.125 (0.025, 0.219) 1.990 (0.890, 0.062) 1.175 (0.075, 0.289) 1.178 (0.078, 0.299)
n = (120, 120, 120) 1.2 1.074 (-0.126, 0.135) 1.219 (0.019, 0.200) 1.994 (0.794, 0.059) 1.256 (0.056, 0.238) 1.258 (0.058, 0.246)
1.1 1.013 (-0.087, 0.114) 1.117 (0.017, 0.184) 1.973 (0.873, 0.092) 1.144 (0.044, 0.215) 1.148 (0.048, 0.224)
Scenario 2
n = (60, 60, 60) 1.378 1.059 (-0.320, 0.180) 1.502 (0.124, 0.557) 2.000 (0.622, 0.066) 1.628 (0.25, 0.657) 1.670 (0.292, 0.658)
1.189 1.006 (-0.183, 0.139) 1.291 (0.102, 0.503) 1.994 (0.805, 0.068) 1.399 (0.21, 0.616) 1.446 (0.257, 0.598)
n = (90, 90, 90) 1.378 1.086 (-0.293, 0.218) 1.457 (0.079, 0.447) 2.003 (0.625, 0.087) 1.546 (0.168, 0.549) 1.577 (0.198, 0.526)
1.189 1.019 (-0.170, 0.174) 1.259 (0.070, 0.395) 1.986 (0.797, 0.081) 1.337 (0.148, 0.484) 1.369 (0.180, 0.479)
n = (120, 120, 120) 1.378 1.111 (-0.267, 0.237) 1.414 (0.036, 0.338) 2.006 (0.628, 0.102) 1.474 (0.096, 0.411) 1.485 (0.107, 0.409)
1.189 1.025 (-0.164, 0.185) 1.216 (0.027, 0.307) 1.977 (0.788, 0.132) 1.272 (0.082, 0.381) 1.282 (0.093, 0.382)
Scenario 3
n = (60, 60, 60) 1.256 1.058 (-0.199, 0.167) 1.299 (0.042, 0.345) 2.011 (0.754, 0.246) 1.400 (0.144, 0.490) 1.446 (0.189, 0.515)
0.903 0.964 ( 0.062, 0.137) 0.947 (0.044, 0.323) 1.983 (1.081, 0.068) 1.032 (0.130, 0.435) 1.086 (0.183, 0.471)
n = (90, 90, 90) 1.256 1.102 (-0.154, 0.255) 1.292 (0.036, 0.284) 2.003 (0.746, 0.073) 1.338 (0.082, 0.350) 1.362 (0.106, 0.370)
0.903 0.957 ( 0.054, 0.206) 0.932 (0.029, 0.253) 1.977 (1.075, 0.086) 0.974 (0.071, 0.318) 0.993 (0.091, 0.346)
n = (120, 120, 120) 1.256 1.122 (-0.135, 0.189) 1.284 (0.028, 0.240) 2.005 (0.748, 0.089) 1.324 (0.067, 0.301) 1.328 (0.071, 0.319)
0.903 0.940 ( 0.038, 0.144) 0.917 (0.015, 0.224) 1.965 (1.062, 0.105) 0.948 (0.045, 0.277) 0.951 (0.048, 0.291)
Scenario 4
n = (60, 60, 60) 0.047 0.695 (0.648, 0.368) 0.964 (0.917, 0.927) 1.960 (1.913, 0.233) 0.089 (0.042, 0.091) 0.100 (0.053, 0.130)
0.456 1.028 (0.571, 0.538) 3.237 (2.781, 4.707) 3.894 (3.437, 41.735) 0.530 (0.074, 0.225) 0.563 (0.107, 0.276)
n = (90, 90, 90) 0.047 0.440 (0.393, 0.387) 1.031 (0.984, 0.817) 1.641 (1.594, 8.895) 0.079 (0.032, 0.055) 0.080 (0.033, 0.061)
0.456 0.925 (0.469, 0.359) 2.450 (1.993, 1.572) 2.324 (1.868, 8.906) 0.505 (0.049, 0.159) 0.513 (0.056, 0.171)
n = (120, 120, 120) 0.047 0.306 (0.259, 0.345) 1.173 (1.126, 1.059) 1.888 (1.841, 0.308) 0.073 (0.025, 0.046) 0.073 (0.026, 0.046)
0.456 0.838 (0.382, 0.344) 2.548 (2.091, 1.893) 2.020 (1.564, 0.406) 0.492 (0.036, 0.140) 0.494 (0.037, 0.144)
6. Real Data Analysis
6.1. The Alzheimer’s Disease Data Analysis
The first data set that we analyzed here for illustration is a subset of the longitudinal cohort data on Alzheimer’s Disease
(AD) from Alzheimer’s Disease Research Center (ADRC) at Washington University. The dataset is available in the R
package DiagTest3Grp (https://www.cran.org). In this data set, measurements of 14 neuro-psychological markers
were collected from 118 independent individuals of age 75 among which 44 individuals were non-demented, 43 were very
mildly demented, and 21 individuals were mildly demented. It is now commonly accepted that treatment for Alzheimer’s
disease is a rather complicated issue and more clinically useful strategy is to apply appropriate interventions for earlier
stage patients with relatively mild conditions ([20],[21]). Therefore it is meaningful to differentiate three or even more
categories of patients with ascending disease severity and subsequently offer category-specific treatments.
Due to some missing observations, we deleted 10 individuals from the data set for our analysis. Note that values of these
fourteen biomarkers can be negative. Furthermore, as we can see from the boxplot in Figure 2 and density plot in 3, there
is a clear decreasing trend in the distributions of all the fourteen neuro-psychological markers across the dementia status.
This shows the potential discrimination power of these individual markers. This observation was further evident by their
individual discrimination power in terms of EHUM values where factor1, ktemp and zpsy004 have the highest individual
EHUM values ranging from 0.70 to 0.78. Even the lowest EHUM values for the individual markers lie above 0.3, clearly
much larger than the lowest EHUM value for random guess which is 0.17 in this case.
To see the improvement in discrimination accuracy by combing these individual markers over the individual markers
and to facilitate comparison, we employed all the six combining methods discussed in Section 3. The estimated EHUM
values with their respective standard errors using all the six methods are reported in Table 4 along with the coefficient
parameter estimates and their respective bootstrap standard errors. We note that the empirical method has the highest
EHUM value of 0.832 which is a substantive improvement than the highest individual biomarker’s EHUM value of 0.784.
The SSHUM method has the second largest EHUM value of 0.828, also a substantive improvement over the individual
biomarkers. However, as we can see the Min-Max and Naive method (where we assumed equal weight for each individual
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biomarkers) have the lowest EHUM values of 0.80 and 0.792, respectively.
National Institute of Aging-Alzheimer’s Association (NIA-AA) published research criteria for AD diagnosis in 2011
using biomarkers information. In addition to dementia due to AD, other stages of interest include prodromal AD (mild
cognitive impairment) and preclinical AD (individuals with normal condition with AD pathology). The markers evaluated
in our analysis may also offer useful insight for such mutli-stage diagnosis.
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Figure 2. Boxplot for individual and combined biomarkers for Alzheimer data set.
Table 3. Empirical HUM values (with bootstrap standard errors) for the individual biomarkers for the AKI and Alzheimer
data sets.
Alzheimer data ERICCA data
Individual biomarkers HUM (se) Individual biomarkers HUM (se)
FACTOR1 0.774 (0.056) NGAL 0 hours 0.179 (0.029)
ktemp 0.784 (0.055) NGAL 6 hours 0.222 (0.034)
kpar 0.600 (0.065) NGAL 12 hours 0.273 (0.040)
kfront 0.654 (0.059) NGAL 24 hours 0.315 (0.042)
zpsy004 0.718 (0.058)
zpsy005 0.316 (0.064)
zpsy006 0.442 (0.069)
zinfo 0.643 (0.065)
zbentc 0.506 (0.060)
zbentd 0.144 (0.047)
zboston 0.590 (0.066)
zmentcon 0.367 (0.065)
zworflu 0.561 (0.066)
zassc 0.648 (0.066)
6.2. The ERICCA data analysis
Here we analyze an acute kidney injury dataset following a heart surgery to illustrate our proposed method. We consider the
data from the Effect of Remote Ischemic Preconditioning on Clinical Outcomes in Patient Undergoing Coronary Artery
Bypass Graft Surgery (ERICCA) trial where a group of 1612 patients participated in a cardiovascular surgery and were
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Figure 3. Density plot for individual and combined biomarkers for Alzheimer data set.
Table 4. Estimated coefficients and the HUM values (with standard errors in parenthesis) for the Alzheimer’s disease data
using Naive method, Empirical, SSHUM, NSHUM, Fre´chet, Parametric and Min-max methods based on 100 repetitions.
Biomarkers βNaive βEmpirical βSSHUM βNSHUM βFrechet βParametric βMin−Max
FACTOR1 0.267 0.437 (0.2056) -0.092 (0.2457) 0.431 (0.2235) 0.192 (0.2064) -0.032 (0.2235) -
ktemp 0.267 0.117 (0.1613) 0.233 (0.1332) 0.155 (0.1218) 0.192 (0.1564) 0.203 (0.1774) -
kpar 0.267 0.154 (0.1379) 0.261 (0.1278) 0.229 (0.1389) 0.161 (0.1526) 0.019 (0.2000) -
kfront 0.267 -0.005 (0.1590) -0.006 (0.1577) -0.030 (0.1628) 0.343 (0.1713) 0.232 (0.1860) -
zpsy004 0.267 0.685 (0.1953) 0.447 (0.0986) 0.433 (0.0911) 0.667 (0.2171) 0.495 (0.2301) -
zpsy005 0.267 0.173 (0.1604) 0.063 (0.1683) 0.071 (0.1381) 0.192 (0.1909) 0.082 (0.2191) -
zpsy006 0.267 0.180 (0.1841) 0.402 (0.1270) 0.318 (0.1263) 0.192 (0.1915) 0.423 (0.2071) -
zinfo 0.267 -0.283 (0.2664) -0.447 (0.1730) -0.433 (0.2389) -0.073 (0.2699) -0.244 (0.2657) -
zbentc 0.267 -0.043 (0.1905) 0.268 (0.1697) 0.063 (0.1599) -0.262 (0.2033) 0.249 (0.2205) -
zbentd 0.267 0.007 (0.2093) -0.401 (0.2179) -0.291 (0.2478) 0.001 (0.2293) -0.067 (0.2403) -
zboston 0.267 0.173 (0.1983) -0.128 (0.1641) 0.183 (0.1662) 0.000 (0.2045) 0.303 (0.2149) -
zmentcon 0.267 0.235 (0.2564) 0.139 (0.1466) 0.288 (0.1462) -0.196 (0.2704) -0.377 (0.2172) -
zworflu 0.267 -0.192 (0.2175) -0.138 (0.1899) 0.021 (0.1797) -0.065 (0.2387) 0.326 (0.2352) -
zassc 0.267 -0.189 (0.2580) -0.125 (0.2503) -0.222 (0.2379) 0.384 (0.2838) -0.079 (0.2395) -
HUM 0.792 0.832 (0.0545) 0.874 (0.0179) 0.849 (0.0177) 0.812 (0.0614) 0.817 (0.0584) 0.800 (0.0509)
observed for one year after the surgery ([18, 22]). All the patients were randomized to two different methods of surgeries
namely Remote Ischemic Conditioning (RIC) or Sham Preconditioning. During the study period, some patients developed
a disease called Acute Kidney Injury (AKI) along with few other diseases post-surgery. The AKI was recorded as a multi-
category ordinal outcome with four levels based on the severity level. The data also includes cardiovascular death and
all-cause mortality at 1 year (binary), non-fatal Myocardial Infarction (MI) (binary) and coronary revascularization or
stroke at 1 year (binary). In literature, studies on prediction of AKI after cardiac surgery has been performed in several
occasions. Assuming AKI as a binary outcome, [23] found that the serum Neutrophil Gelatinase Associated Lipocalin
(NGAL) measurements taken at 0 (before surgery), 6, 12 and 24 hours after surgery are significant influential biomarkers
in the development of AKI. In addition, they showed that for the risk-stratification of patients prior to cardiac surgery
for AKI may be improved by adding pre-oprative levels of NGAL to existing risk scores where existing risk score was
calculated based on age, gender, diabetes mellitus, hypertension, peripheral vascular disease, previous Coronary Artery
Bypass Graft type of surgery planned, use of intra-aortic ballon pump and few other baseline covariates. However, the
main limitation of their study is that they did not consider the multiple categories of the AKI outcome. Instead, they
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converted it to binary outcome where level 0 stands for no AKI and level 1 stands for any of the 1,2,3 levels of AKI in the
data.
To illustrate the proposed method, we consider the AKI within 72 hours of surgery as our multi-category outcome
which are leveled as 0 (none), 1, 2, 3 as per the international Kidney Disease: Improving Global Outcomes classification
(KDIGO) criteria on serum creatinine. Since level 3 has only a few observations, we combine the levels 2 and 3 into a
single category denoted as the highest risk group. Therefore, in the following analysis, the AKI has three levels/categories.
Our biomarkers of interest in predicting AKI are individual NGAL at 0 (before surgery), 6, 12 and 24 hours after surgery
and their different combinations using different methods. In a previous analysis, [23] observed that there is a significant
increase in AKI as the individual’s pre-operative NGAL increases from the first to the third tertile (>220 ng/L). Hence
they considered only the individuals from the third tertile and concluded that the pre-operative NGAL is a significant
predictor in predicting binary AKI. There are 305 individuals in our sample after discarding all the missing observations.
Among these subjects, 172 patients did not develop AKI within the 72 hours of surgery (AKI=0), 99 patients developed
level 1 AKI, and 34 developed level 2 (i.e., combined levels 2 and 3 in original scale) AKI.
Note that larger values of the NGAL measurements indicate the higher level of severity of AKI. Since the NGAL
measurements are highly skewed-distributed and large in number, so we transformed them into the logarithm scale to scale
down those high numbers and make the distributions close to normal distributions. Considering logarithmic transformation
of the biomarkers is a common strategy for this type of data analysis (see e.g., [2]). To see the visual discrimination
power of these individual log of NGAL measurements, the box plots and the density plots are shown in Figures 4 and
5, respectively. The estimated empirical HUM values for the individual NGAL at four different time points are 0.179
(at 0 hours), 0.222 (at 6 hours), 0.273 (at 12 hours), and 0.315 (at 24 hours). These values are also reported in Table 3,
along with their respective standard error. Recall that for random guess the HUM value is 1/6=0.1667 when the disease
outcome variable has three possible outcomes. That is to say HUM value for any biomarker less that 0.1667 indicates
that the biomarker is weaker in predicting the disease outcome and should be avoided from the prediction model. In this
case, all the NGAL measurements can be included in the prediction model. Further, it is noticed that as the time of NGAL
measurement increases from 0 hours to 24 hours, the HUM value increases to almost two times that of the 0 hours. It
indicates the strong discrimination power of the NGAL biomarker in predicting AKI as time progresses after surgery.
Further, we treat the four NGAL measurements as four biomarkers and apply our proposed SSHUM method to combine
these markers. As comparison, a naive linear combination approach with equal weights on the four markers is also
constructed. The distributions of these combined markers are also displayed in Figures 4 and 5. It is noted that SSHUM
separates the three class in the most effective way.
Further, we obtain the HUM values for other existing methods along with their respective optimal linear combination
estimates. The estimates along with their bootstrap standard errors are reported in Table 5. We note that all the linear
combining methods yield larger HUM values than that of the individual biomarkers and the naive equal weight method.
The proposed sigmoid approximation yields the highest HUM value compared to the other existing methods. Although
the proposed method combines the time-varying NGAL measurements in a more effective way than the others, still further
studies may be required to support the effectiveness of such NGAL measurements and their combining factor in predicting
AKI.
Table 5. Estimated optimal coefficients and the HUM values (with standard errors in parenthesis) for the ERICCA dataset
using naive method, empirical method, SSHUM, NSHUM, Fre´chet, parametric and Min-Max methods based on 100
repetitions.
Biomarkers naive Empirical SSHUM NSHUM Frechet Parametric Min−Max
NGAL 0 hours 0.5 0.412 (0.2869) -0.208 (0.3078) -0.097 (0.3142) 0.234 (0.0798) 0.236 (0.3636) -
NGAL 6 hours 0.5 -0.050 (0.4074) -0.660 (0.3201) -0.387 (0.3196) -0.382 (0.1083) 0.593 (0.3659) -
NGAL 12 hours 0.5 0.594 (0.2098) 0.360 (0.3320) 0.176 (0.3377) 0.566 (0.0426) 0.590 (0.2563) -
NGAL 24 hours 0.5 0.688 (0.1917) 1.508 (0.2570) 0.900 (0.2665) 0.692 (0.0462) 0.494 (0.1762) -
HUM 0.281 0.317 (0.0154) 0.326 (0.0140) 0.325 (0.0135) 0.312 (0.0054) 0.287 (0.0182) 0.303 (0.0079)
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Figure 4. Boxplot for individual and combined NGALs for ERICCA data set. The top 4 plots represents the NGAL levels at 0, 6, 12 and 24 hours after the surgery for 3 levels
of AKI. Bottom left diagram shows the boxplots for Naive method (i.e., linear combination of covariates with equal positive coefficients) and the bottom right diagram shows the
boxplots for SSHUM method.
7. Discussion
Improving diagnostic accuracy by combining multiple biomarkers have been studied both for binary and multi-category
outcomes. In this article, we have extended the idea of direct maximization of empirical hyper-volume under manifolds,
specifically volume under surface (VUS) proposed by [14], to a smoothing approximation of it using a class of smooth
CDFs which is controlled by a tuning parameter. In particular, we have used the logistic CDF (sigmoid function) and
normal CDF to operationalize our proposed method. We have also discussed about the choice of the tuning parameter.
Consistency and asymptotic normality of the coefficient estimators using the proposed method have been established.
Furthermore, through simulation studies we observe that the proposed method is computationally less challenging than
the direct maximization of the EHUM, which is non-smooth and non-differentiable. We also note that the performance of
the proposed method heavily depends on the choice of the tuning parameter λ, with lower values of λ leading to results
very similar to the empirical method with less bias but large variability. This is a problem of bias-variance trade-off which
we have discussed in considerable detail in Section 2.3. Results from our simulation study and the two real medical data
analyses have shown that shown that in general, the proposed method outperforms other methods including the empirical
method. To obtain the estimated coefficient vectors maximizing SHUM, we considered the step-down algorithm. However,
in future, coming up with advanced computational aids and fast global optimization algorithms for simultaneous estimation
of the whole coefficient vector (instead of estimating one at a time using step-down algorithm) maximizing SHUM might
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Figure 5. Density plot for individual and combined NGALs for ERICCA data set.
further improve the solutions.
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Appendix
A1: Proof of Theorem 1
Assuming (A1)-(A3), [14] proved the consistency of β̂E , an empirical HUM based estimator of β for three-category
ordinal outcome, using the result of maximum rank correlation type estimators by [24] . In fact, it can be shown that β̂E
is consistent estimator of β for any number of categories. The above result is equivalent to
sup
β∈B
|DE(β)−D(β)| = op(1),
i.e., supβ∈B |DE(β)−D(β)| converges to 0 in probability.
Similarly, to prove the probability convergence of β̂sn , the proposed SSHUM based estimator, we have to show that
sup
β∈B
|Dsn(β)−D(β)| = op(1).
Note that, using the triangular inequality, we can write
sup
β∈B
|Dsn(β)−D(β)| = sup
β∈B
|Dsn(β)−DE(β) +DE(β)−D(β)| ,
≤ sup
β∈B
|Dsn(β)−DE(β)|+ sup
β∈B
|DE(β)−D(β)|
= sup
β∈B
|Dsn(β)−DE(β)|+ op(1). (7)
Hence, to prove the consistency of β̂sn , it is sufficient to prove the following lemma.
Lemma 1 Under the assumptions (A1)-(A3),
sup
β∈B
|DE(β)−Dsn(β)| p−→ 0
as n→∞.
Proof of Lemma 1
For binary outcome, [6] proved the consistency of βsn by showing that
sup
β∈B
|Dsn(β)−DE(β)| = op(1).
Here, we use the same idea to prove that supβ∈B |Dsn(β)−DE(β)| = op(1) for multi-category ordinal outcome. Define
an equivalent definition of DE(β) as
DE(β) = C
∑
i1 6=i2 6=···6=iM
I(YMiM > · · · > Y1i1)I(βTZiM iM−1 > 0)I(βTZiM−1iM−2 > 0) · · · I(βTZi2i1 > 0),
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where C =
1
n(n− 1) · · · (n−M + 1) , Zij+1ij = X(j+1)ij+1 −Xjij , and Yjij , j = 1, 2, · · · ,M are defined as Yjij = j if
the ij-th observation belongs to the j-th category, otherwise 0.
Similarly, we define an equivalent definition of SSHUM as
Dsn(β) = C
∑
i1 6=i2 6=···6=iM
I(YMiM > · · · > Y1i1)sn(βTZiM iM−1)sn(βTZiM−1iM−2) · · · sn(βTZi2,i1)
For any δ > 0, we can write
|DE(β)−Dsn(β)| ≤ Tn1 + Tn2
where
Tn1 = C
∑
i1 6=i2 6=···6=iM
I(YMiM > · · · > Y1i1)∣∣I(βTZiM iM−1 > 0) · · · I(βTZi2i1 > 0)− sn(βTZiM iM−1) · · · sn(βTZi2i1)∣∣
I
(
max
1≤j≤M−1
∣∣βTZij+1ij ∣∣ ≥ δ)
and
Tn2 = C
∑
i1 6=i2 6=···6=iM
I(YMiM > · · · > Y1i1)∣∣I(βTZiM iM−1 > 0) · · · I(βTZi2i1 > 0)− sn(βTZiM iM−1) · · · sn(βTZi2i1)∣∣
I
(
max
1≤j≤M−1
∣∣βTZij+1ij ∣∣ < δ) .
[6] showed that on the set {|x| ≥ δ}, |sn(x)− I(x > 0)| ≤ exp (− |x| /σn) < exp (−δ/σn)→ 0 uniformly as σn → 0.
Following this, it can be shown that
sn(x1)→ I(x1 > 0) uniformly on the set {|x1| ≥ δ},
sn(x2)→ I(x2 > 0) uniformly on the set {|x2| ≥ δ},
...
and sn(xM−1)→ I(xM−1 > 0) uniformly on the set {|xM−1| ≥ δ}.
Statist. Med. 2019, 00 1–22 Copyright c© 2019 John Wiley & Sons, Ltd. www.sim.org 19
Prepared using simauth.cls
Statistics
in Medicine Maiti et al
It implies that on the set {max1≤i≤M−1 |xi| ≥ δ}, sn(xi)→ I(xi > 0) uniformly for all i = 1, 2, · · · ,M − 1. Following
this, we can write
|sn(x1)sn(x2) · · · sn(xM−1)− I(x1 > 0)I(x2 > 0) · · · I(xM−1 > 0)|
≤ |sn(x1)− I(x1 > 0)| sn(x2) · · · sn(xM−1) +
I(x1 > 0) |sn(x2) · · · sn(xM−1)− I(x2 > 0) · · · I(xM−1 > 0)| ,
≤ |sn(x1)− I(x1 > 0)| sn(x2) · · · sn(xM−1) +
I(x1 > 0) |sn(x2)− I(x2 > 0)| sn(x3) · · · sn(xM−1) +
I(x1 > 0)I(x2 > 0) |sn(x3) · · · sn(xM−1)− I(x3 > 0) · · · I(xM−1 > 0)| ,
...
≤ |sn(x1)− I(x1 > 0)| sn(x2) · · · sn(xM−1) +
I(x1 > 0) |sn(x2)− I(x2 > 0)| sn(x3) · · · sn(xM−1) + · · ·+
I(x1 > 0)I(x2 > 0) · · · I(xM−2 > 0) |sn(xM−1)− I(xM−1 > 0)| ,
= op(1) + op(1) + · · ·+ op(1) = op(1).
Now replacing xj by βTZij+1,ij in the above derivation, we can see that Tn1 converges to 0 uniformly on set B. The
second term can be bounded above as
Tn2 ≤ C
∑
i1 6=i2 6=···6=iM
I
(
max
1≤j≤M−1
∣∣βTZij+1ij ∣∣ < δ) .
Again by the uniform convergence of the U-process, the right hand side of the above equation converges to
P
(
max1≤j≤M−1
∣∣βTZij+1ij ∣∣ < δ) almost surely on B. Further, using order statistic result, we can write
P
(
max
1≤j≤M−1
∣∣βTZij+1ij ∣∣ < δ) = P (∣∣βTZiM iM−1∣∣ < δ, ∣∣βTZiM−1iM−2∣∣ < δ, · · · , ∣∣βTZi2i1∣∣ < δ)
≤ P (∣∣βTZij+1ij ∣∣ < δ)
for all j = 1, 2, · · · ,M − 1 over B. Under the assumptions (A2) and (A3), it can be shown that P (∣∣βTZij+1ij ∣∣ < δ)
converges to 0 uniformly over B as δ goes to 0. Hence, it proves that supβ∈B |Dsn(β)−DE(β)| = op(1).
A2: Proof of Theorem 2
For simplicity, we denote β(θ) = β and β(θ̂) = β̂. Note that
β̂sn = arg maxθ
Dsn(β).
Define
Gn(β) =
∂
∂θ
Dsn(β)
=
1
M∏
j=1
nj
n1∑
i1=1
n2∑
i2=1
· · ·
nM∑
iM=1
∂
∂θ
[
sn(β
T (XMiM −X(M−1)i(M−1))) · · · sn(βT (X2i2 −X1i1))
]
=
1
N
n1∑
i1=1
n2∑
i2=1
· · ·
nM∑
iM=1
Ψ(X1i1 ,X2i2 , · · · ,XMiM ;β)
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where
Ψ(X1i1 ,X2i2 , · · · ,XMiM ;β) =
∂
∂θ
[
sn(β
T (XMiM −X(M−1)i(M−1))) · · · sn(βT (X2i2 −X1i1))
]
,
=
∂
∂θ
[
M−1∏
j=1
sn(β
TZi(j+1)ij )
]
=
M−1∑
l=1
[
M−1∏
j=1
sn(β
TZi(j+1)ij )
] (
1− sn(βTZi(l+1)il)
)
Z
(−d)
i(l+1)il
= κn(X1i1 ,X2i2 , · · · ,XMiM ;β)
M−1∑
l=1
(
1− sn(βTZi(l+1)il)
)
Z
(−d)
i(l+1)il
with Zij+1ij = X(j+1)ij+1 −Xjij , Z(−d) = (Z1, · · · , Zd−1)T and N =
M∏
j=1
nj . By definition of β̂sn ,
Gn(β̂sn) = 0,
and β0 is such that
E(Ψ(X1i1 ,X2i2 , · · · ,XMiM ;β0)) = 0.
Since Gn(β) is differentiable function, and
√
n(θ̂sn − θ0) = op(1) (result from Theorem 1), hence using Taylor’s series
expansion we can write
0 = Gn(β̂sn) = Gn(β0) +G
′
n(β0)(θ̂sn − θ0) +Rn
where G
′
n(β0) =
∂
∂θT
Gn(β) |β=β0 is a d× d matrix.
Assuming (A4), we can write
√
n(θ̂sn − θ0) =
[
−G′n(β0)
]−1√
nGn(β0) +
[
G
′
n(β0)
]−1√
nRn. (8)
Note that following Theorem 1 where we have (θ̂sn − θ0) = op(1), we can write
√
nRn
p−→ 0.
Following the large sample distribution of multivariate U-statistic (see [25]), it can be shown that
√
nGn(β0)
d−→ Nd−1 (0,B(β0))
where
B(β0) =
M∑
m=1
ρ2mΣψm ,
Σψm = V ar(Ψ˜m1(Xm1)),
Ψ˜m1(Xm1) = E(Ψ(X11,X21, · · · ,XM1)|Xm1),
ρ2m =
n
nm
, m = 1, 2, · · · ,M.
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Similarly, using the weak law of large numbers, it can be shown that
−G′n(β0) =
1
N
n1∑
i1=1
n2∑
i2=1
· · ·
nM∑
iM=1
− ∂
∂θT
Ψ(Xi1 ,Xi2 , · · · ,XiM ;β)
p−→ A(β0)
where
A(β0) = E
(
− ∂
∂θT
Ψ(Xi1 ,Xi2 , · · · ,XiM ;β) |β=β0
)
.
Using Slustky’s theorem in equation (8), we can write
√
n(θ̂n − θ0) d−→ Nd−1 (0,Σ(β0))
where Σ(β0) = A(β0)−1B(β0)[A(β0)−1]T , known as sandwich variance formula.
Explicit form of the first derivative of Ψ(Xi1 ,Xi2 , · · · ,XiM ;β) is given as follows:
∂
∂θT
Ψ(Xi1 ,Xi2 , · · · ,XiM ;β) =
∂2
∂θ∂θT
[
M−1∏
j=1
sn(β
TZi(j+1)ij )
]
=
((
∂2
∂θu∂θv
[
M−1∏
j=1
sn(β
TZi(j+1)ij )
]))
, u, v = 1, 2, · · · , d− 1,
where
∂2
∂θu∂θv
[
M−1∏
j=1
sn(β
TZi(j+1)ij )
]
=
M−1∑
l=1
κn(β)δn;v(β)
(
1− sn(βTZi(l+1)il)
)
Zi(l+1)il;u −
M−1∑
l=1
κn(β)sn(β
TZi(l+1)il)
(
1− sn(βTZi(l+1)il)
)
Zi(l+1)il;uZi(l+1)il;v,
κn(β) =
M−1∏
j=1
sn(β
TZi(j+1)ij )
and
δn;v(β) =
M−1∑
k=1
(
1− sn(βTZi(k+1)ik)
)
Zi(k+1)ik;v
Ψ(Xi1 ,Xi2 , · · · ,XiM ;β)Ψ(Xi1 ,Xi2 , · · · ,XiM ;β)T
=
[
κn(β)
M−1∑
l=1
(
1− sn(βTZi(l+1)il)
)
Z
(−d)
i(l+1)il
][
κn(β)
M−1∑
l=1
(
1− sn(βTZi(l+1)il)
)
Z
(−d)
i(l+1)il
]T
= κn(β)
2
M−1∑
l=1
M−1∑
k=1
(
1− sn(βTZi(l+1)il)
) (
1− sn(βTZi(k+1)ik)
)
Z
(−d)
i(l+1)il
Z
(−d)T
i(k+1)ik
.
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